Faron Pharma celebrates publication of bexmarilimab results

Faron Pharmaceuticals Ltd - Finland-based clinical-stage biopharmaceutical company - Says that results from its Phase 1/2 MATINS trial of bexmarilimab have been published in Cell Reports Medicine,...

Related Keywords

Finland ,Holly Beveridge ,Alliance News ,Faron Pharmaceuticals Ltd ,Alliance News Ltd ,Cell Reports Medicine ,All Rights ,Markets ,